ECJ (Judgment) Medicinal products for human use – Orphan medicinal products – Application for marketing authorisation for the generic version of the orphan medicinal product imatinib – EMA decision refusing to validate the application for marketing authorisation – Market exclusivity
S. Frimodt Nielsen (Rapporteur), P
T-140/12, [2015] EUECJ T-140/12
Bailii
European, Commercial
Updated: 27 December 2021; Ref: scu.541744